許 昭俊

Medicine & Life Sciences

1. Stroke 100%
2. Population 81%
3. Dementia 66%
4. Sudden Hearing Loss 48%
5. Sensorineural Hearing Loss 41%
6. Cohort Studies 39%
7. Parkinson Disease 37%
8. Meningeal Tuberculosis 36%
9. Chronic Periodontitis 33%
10. Herpes Zoster 30%
11. Rheumatic Diseases 30%
12. Case-Control Studies 30%
13. Odds Ratio 29%
14. Macular Degeneration 28%
15. Alzheimer Disease 28%
16. Autoimmune Diseases 24%
17. Metoclopramide 23%
18. Type A Botulinum Toxins 21%
19. Databases 20%
20. Datasets 20%
21. Movement Disorders 20%
22. Time-to-Treatment 20%
23. Cerebral Hemorrhage 19%
24. Logistic Models 18%
25. Sleep 18%
26. Obstructive Sleep Apnea 18%
27. Basal Ganglia 18%
28. Migraine Disorders 18%
29. Magnetic Resonance Imaging 18%
30. Parkinsonian Disorders 17%
31. National Health Programs 16%
32. Coronary Disease 16%
33. Aspirin 16%
34. Headache 16%
35. Health Insurance 16%
36. pantothenate kinase 16%
37. Cognitive Dysfunction 15%
38. Diabetic Neuropathies 15%
39. Hyperlipidemias 15%
40. Epilepsia Partialis Continua 14%
41. Pantothenate Kinase-Associated Neurodegeneration 14%
42. Herpes Zoster Ophthalmicus 14%
43. Young Adult 14%
44. Pyogenic Liver Abscess 13%
45. Meningeal Arteries 13%
46. Radial Neuropathy 13%
47. Tigers 13%
48. Hypertension 13%
49. Hearing Disorders 13%